Dr. Pencho Georgiev Ambulatory For Individual Practice For Medical Aid For Clinical Hematology EOOD — Clinical Trial Site

8 Registered trials

6 Currently recruiting

Organisation

Dr. Pencho Georgiev Ambulatory For Individual Practice For Medical Aid For Clinical Hematology EOOD

Location

Plovdiv, Bulgaria

Identifier

ORG-100053144

Address

Ulitsa Perushtitsa 13b 2nd Floor, 4002, Bulgaria

Departments

Ambulatory for Individual Practice for Medical Aid for internal diseases and Clinical Hematology,
BG008A
Hematology
N/A
Not applicable

Clinical trials at this site (8)

Search interface

A study to find how well budoprutug (TNT119) works and how safe it is in participants with immune thrombocytopenia Not authorised

2024-519745-30-00 Immune Thrombocytopenia (ITP) 9
A phase 3 trial comparing elritercept versus epoetin alfa for treatment of anemia due to lower-risk MDS in ESA-naïve adults who require RBC … Recruiting

2025-523544-12-00 Myelodysplastic neoplasms/syndromes (MDS) 5 2026-06-02
A study to find how well budoprutug (TNT119) works and how safe it is in participants with immune thrombocytopenia Recruiting

2024-519745-30-01 Immune Thrombocytopenia (ITP) 9 2025-12-19
A study to evaluate the efficacy of APG-2575 (Lisaftoclax) plus azacitidine (AZA) vs. placebo plus AZA in newly diagnosed adult subjects wit… Recruiting

2024-517247-31-00 Newly Diagnosed Higher Risk Myelodysplastic Syndrome 5 2025-07-07
A study of elritercept to treat transfusion-dependent anemia due to very low, low, or intermediate risk myelodysplastic syndromes Recruiting

2024-516009-22-00 myelodysplastic neoplasms/syndromes (MDS) 5 2025-04-30
A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Lisaftoclax (APG-2575) in Previously Treated Patients with Chro… Recruiting

2023-508005-24-00 Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma 5 2024-08-01
Phase 1/2 Study of Oral Nuvisertib (TP-3654) in Patients with Myelofibrosis Recruiting

2022-502597-16-00 Intermediate or High-risk Primary or Secondary Myelofib 9 2023-10-27
A phase 1/2 study of SLN124 in patients with Polycythemia Vera Ended

2023-503544-13-00 Polycythemia Vera 9 2023-11-02